{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:21:00Z","timestamp":1793064060354,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":394,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jacc.2024.02.037","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T18:59:21Z","timestamp":1713812361000},"page":"1688-1701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Malignant Hypertension:A Systemic Cardiovascular Disease"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-6535","authenticated-orcid":false,"given":"Romain","family":"Boulestreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"\u015apiewak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Januszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-211X","authenticated-orcid":false,"given":"Reinhold","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz J.","family":"Guzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Januszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lorenza","family":"Muiesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Persu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Sarafidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zaleska-\u017bmijewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert-Jan H.","family":"van den Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz H.","family":"Messerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.02.037_bib1","series-title":"High Blood Pressure","author":"Pickering","year":"1955"},{"key":"10.1016\/j.jacc.2024.02.037_bib2","series-title":"Hypertension: A Companion to Braunwald's Heart Disease","author":"Elliott","year":"2024"},{"key":"10.1016\/j.jacc.2024.02.037_bib3","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/01.hjh.0000249710.21146.38","article-title":"Ethnic disparities in the incidence, presentation and complications of malignant hypertension","volume":"24","author":"van den Born","year":"2006","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib4","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/HYPERTENSIONAHA.123.21226","article-title":"Characteristics and prognosis of patients with hypertensive encephalopathy: a French nationwide cohort study","volume":"80","author":"Halimi","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2024.02.037_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/HJH.0000000000001913","article-title":"Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort","volume":"37","author":"Rubin","year":"2019","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib6","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.115.05241","article-title":"Increasing trend in admissions for malignant hypertension and hypertensive encephalopathy in the United States","volume":"65","author":"Polgreen","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2024.02.037_bib7","article-title":"Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management","volume":"13","author":"Mazzierli","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacc.2024.02.037_bib8","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1097\/HJH.0b013e3282efb213","article-title":"The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients","volume":"25","author":"van den Born","year":"2007","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib9","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1681\/ASN.2018020184","article-title":"C5b9 Formation on endothelial cells reflects complement defects among patients with renal thrombotic microangiopathy and severe hypertension","volume":"29","author":"Timmermans","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2024.02.037_bib10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1172\/JCI104124","article-title":"Aldosterone secretion and primary and malignant hypertension","volume":"39","author":"Laragh","year":"1960","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2024.02.037_bib11","first-page":"113","article-title":"Renin secretion in the patient with hypertension. Relationship to intrarenal blood flow distribution","volume":"24","author":"Hollenberg","year":"1969","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2024.02.037_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.amjhyper.2007.02.018","article-title":"The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension","volume":"20","author":"van den Born","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1152\/ajplegacy.1976.230.3.849","article-title":"Effects of saline drinking on malignant course of renal hypertension in rats","volume":"230","author":"M\u00f6hring","year":"1976","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2024.02.037_bib14","doi-asserted-by":"crossref","first-page":"I177","DOI":"10.1161\/01.HYP.6.2_Pt_2.I177","article-title":"Malignant hypertensive crisis induced by chronic intrarenal norepinephrine infusion","volume":"6","author":"Lohmeier","year":"1984","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2024.02.037_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/01.HYP.33.1.389","article-title":"Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension","volume":"33","author":"Mervaala","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2024.02.037_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.HYP.35.1.193","article-title":"NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats","volume":"35","author":"Muller","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2024.02.037_bib17","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/ndt\/gfac324","article-title":"Nephrosclerosis in young patients with malignant hypertension","volume":"38","author":"Bureau","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2024.02.037_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ehjcvp\/pvy032","article-title":"ESC Council on hypertension position document on the management of hypertensive emergencies","volume":"5","author":"van den Born","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"10","key":"10.1016\/j.jacc.2024.02.037_bib19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41371-022-00776-9","article-title":"Management of hypertensive crisis: British and Irish Hypertension Society Position document","volume":"37","author":"Kulkarni","year":"2023","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/jhh.2015.112","article-title":"From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency","volume":"30","author":"Cremer","year":"2016","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41440-020-0521-2","article-title":"Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria","volume":"44","author":"Mishima","year":"2021","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2024.02.037_bib22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/HJH.0b013e3283526e47","article-title":"Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study","volume":"30","author":"Shantsila","year":"2012","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.HYP.0000151620.17905.ee","article-title":"Microangiopathic hemolysis and renal failure in malignant hypertension","volume":"45","author":"van den Born","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2024.02.037_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.mcna.2016.09.010","article-title":"Syndromes of thrombotic microangiopathy","volume":"101","author":"Shatzel","year":"2017","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jacc.2024.02.037_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.32.2.127","article-title":"Hypertensive encephalopathy and the neurologic manifestations of malignant hypertension","volume":"32","author":"Healton","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2024.02.037_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/jhh.2009.82","article-title":"Value of retinal examination in hypertensive encephalopathy","volume":"24","author":"Amraoui","year":"2010","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib27","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1097\/HJH.0000000000002950","article-title":"Neurologically asymptomatic patients frequently present cerebral injuries during malignant hypertension: a MRI study","volume":"39","author":"Boulestreau","year":"2021","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib28","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMra2114482","article-title":"Posterior reversible encephalopathy syndrome","volume":"388","author":"Geocadin","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.02.037_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/HYPERTENSIONAHA.108.110395","article-title":"Cerebral hemodynamics during treatment with sodium nitroprusside versus labetalol in malignant hypertension","volume":"52","author":"Immink","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2024.02.037_bib30","article-title":"Malignant hypertension and the role of ophthalmologists: a review article","volume":"14","author":"Mishra","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jacc.2024.02.037_bib31","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1167\/iovs.14-14915","article-title":"Retinal and choroidal changes with severe hypertension and their association with visual outcome","volume":"55","author":"Ahn","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jacc.2024.02.037_bib32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/HJH.0b013e3283430b12","article-title":"Impact of malignant arterial hypertension on the heart","volume":"29","author":"Gosse","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/jhh.2012.26","article-title":"22-Year-old patient with malignant hypertension associated with primary aldosteronism","volume":"27","author":"Prejbisz","year":"2013","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.radcr.2021.11.034","article-title":"A\u00a0case of malignant hypertension with multi-organ injury","volume":"17","author":"Misumi","year":"2022","journal-title":"Radiol Case Rep"},{"key":"10.1016\/j.jacc.2024.02.037_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijcard.2011.11.077","article-title":"A\u00a0comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: the West Birmingham Malignant Hypertension project","volume":"167","author":"Shantsila","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2024.02.037_bib36","article-title":"Case report: area of focus in a case of malignant hypertension","volume":"9","author":"Bosisio","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2024.02.037_bib37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.110.166314","article-title":"Persistent macrovascular and microvascular dysfunction in patients with malignant hypertension","volume":"57","author":"Shantsila","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2024.02.037_bib38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/HJH.0b013e328345023d","article-title":"Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis","volume":"29","author":"van den Born","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib39","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1093\/ndt\/gfq143","article-title":"Long-term renal survival in malignant hypertension","volume":"25","author":"Gonz\u00e1lez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2024.02.037_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.586795","article-title":"Preoperative management of pheochromocytoma and paraganglioma","volume":"11","author":"Fang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jacc.2024.02.037_bib41","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia Chairperson","year":"2023","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib42","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1097\/HJH.0000000000002547","article-title":"The pharmacological management of malignant hypertension","volume":"38","author":"Gosse","year":"2020","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib43","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jama.1996.03540160050032","article-title":"Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?","volume":"276","author":"Grossman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2024.02.037_bib44","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ajh.2009.153","article-title":"Improving survival of malignant hypertension patients over 40 years","volume":"22","author":"Lane","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib45","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1097\/HJH.0000000000001446","article-title":"Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry","volume":"35","author":"Shantsila","year":"2017","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2024.02.037_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2369-13-71","article-title":"Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study","volume":"13","author":"Amraoui","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jacc.2024.02.037_bib47","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/ajh\/hpaa129","article-title":"Hypertensive urgency in Tanzanian adults: a 1-year prospective study","volume":"33","author":"Reis","year":"2020","journal-title":"Am J Hypertens"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724004819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724004819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T01:37:56Z","timestamp":1745977076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724004819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":47,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0735109724004819"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.02.037","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant Hypertension:A Systemic Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}